Auction Closed

The bidding has concluded on this auction. For more information on this auction, please contact us.

Contact TerraCaptus

U.S. Patent No. US8551074
CONNECTOR SYSTEM HAVING A COMPRESSIBLE SEALING ELEMENT AND A FLARED FLUID PATH ELEMENT

      &

U.S. Patent No. US8382704
SYSTEMS AND METHODS OF DELIVERING A DILATED SLURRY TO A PATIENT

      &

U.S. Patent No. US9814827
SYSTEMS AND METHODS OF DELIVERING A DILATED SLURRY TO A PATIENT

      &

U.S. Patent No. US7713232
SYSTEM FOR WASHING AND PROCESSING OF CELLS FOR DELVERY THEREOF TO TISSUE

      &

U.S. Patent App. No. 60/771,206
DELIVERY OF AGENTS TO TISSUE

      &

U.S. Patent App. No. 60/742,224
DELIVERY OF AGENTS TO TISSUE

      &

U.S. Patent App. No. 60/734,035
DELIVERY OF AGENTS TO TISSUE

      &

U.S. Patent No. US9629780
SYSTEM FOR PROCESSING CELLS AND CONTAINER FOR USE THEREWITH

      &

U.S. Patent No. US8414765
SYSTEM FOR PROCESSING CELLS AND CONTAINER FOR USE THEREWITH

      &

U.S. Patent No. US8182444
DELIVERY OF AGENTS SUCH AS CELLS TO TISSUE

      &

European Patent App. No. EP20060836954.5
DELIVERY OF AGENTS TO TISSUE

      &

Canadian Patent App. No. CA2630686
DELIVERY OF AGENTS TO TISSUE

      &

Japanese Patent App. No. JP2009524442
DELIVERY OF AGENTS TO TISSUE

      &

U.S. Patent App. No. US14361357
SYSTEMS AND METHODS FOR INJECTING CELLULAR FLUIDS

      &

U.S. Patent App. No. 61/566,139
SYSTEMS AND METHODS FOR INJECTING CELLULAR FLUIDS

      &

European Patent App. No. EP20120853035
SYSTEMS AND METHODS FOR INJECTING CELLULAR FLUIDS

Restriction #1: The sale of the patents and patent applications in this lot is subject to the provisions of the following Assignment Agreement: (click here to download). The provisions of this Assignment Agreement control, and supersede those of this website's User's Agreement/Terms and Conditions to the extent conflict exists therebetween. Transfer of right, title, and interest in the patents and patent applications of this lot to the winning bidder will be effected only by this Assignment Agreement, which the Seller agrees to complete and execute on behalf of the winning bidder, and which the winning bidder also agrees to execute. Bidders are encouraged to review the Assignment Agreement for details regarding this restriction.

Restriction #2: A maintenance fee is due with government late fee for at least one patent in this lot. Payment of this and any other maintenance fee for the patent(s) is the responsibility of the Buyer. Also, an annuity fee is due with government late fee for at least one patent application in this lot. Payment of this and any other maintenance and annuity fees for the patent(s) and patent application(s) is the responsibility of the Buyer. Similarly, any and all outstanding and future maintenance and annuity fees for all assets in this lot are the responsibility of the Buyer.

Restriction #3: It is noted that at least one patent application in this lot is abandoned, expired, and/or has been withdrawn.

Restriction #4: It is noted that U.S. Patent App. No. 14/361,357 is allowed, and has an issue fee payment deadline of February 22, 2018. If the buyer intends to keep this patent application alive, it is the responsibility of the buyer to pay for the issue fee in this allowed patent application, and to take all other necessary steps and pay all necessary fees and costs to keep this patent application alive.

Restriction #5: It is noted that an Official Action has issued in European Patent App. No. 12853035.9, and has an extendible deadline for response is February 26, 2018. If the buyer intends to keep this patent application alive, it is the responsibility of the buyer to respond to the Official Action, and to take all other necessary steps and pay all necessary fees and costs to keep this patent application alive.
  • Patent Document:
  • Patent or App. No.:
  • Seller:
  • Abstract:
  • US8551074: Download Patent (.PDF) | US8382704: Download Patent (.PDF) | US9814827: Download Patent (.PDF) | US7713232: Download Patent (.PDF) | 60/771,206: Download Patent (.PDF) | 60/742,224: Download Patent (.PDF) | 60/734,035: Download Patent (.PDF) | US9629780: Download Patent (.PDF) | US8414765: Download Patent (.PDF) | US8182444: Download Patent (.PDF) | EP20060836954.5: Download Patent (.PDF) | CA2630686: Download Patent (.PDF) | JP2009524442: Download Patent (.PDF) | US14361357: Download Patent (.PDF) | 61/566,139: Download Patent (.PDF) | EP20120853035: Download Patent (.PDF)
  • 8551074 & 8382704 & 9814827 & 7713232 & 60771206 & 60742224 & 60734035 & 9629780 & 8414765 & 8182444 & 200608369545 & 2630686 & 2009524442 & 14361357 & 61566139 & 20120853035
  • Bayer HealthCare
  • US8551074:Systems for connecting a conduit to an injection needle may include a sealing element positioned on a distal end of the conduit, a first cooperating connector positioned around the length of conduit proximal to the sealing element and a second cooperating connector. The first cooperating connector includes a first cooperating connection mechanism and the second cooperating connector includes a second cooperating connection mechanism having a passage therein. The first cooperating connection mechanism and the second cooperating connection mechanism are adapted to form a connection between the first cooperating connector and the second cooperating connector. The connection causes the compression of the sealing element. The injection needle has a lumen with a diameter flared outward to a larger diameter at a proximal end. The second cooperating connector has a mounting hole connected to the passage and a sleeve around the injection needle so that the sleeve and the injection needle are received within the mounting hole.
    US8382704:A system for delivering a cell-slurry to a patient may include a fluid, cells that are non-dissolvable or immiscible in the fluid, thereby forming the cell-slurry, a syringe adapted to contain the cell-slurry and a supernate of the cell-slurry, the syringe defining a first end having an outlet through which the cell-slurry is delivered to the patient, a fluidizing system associated with the syringe and adapted to effect dilation of the cell-slurry with a portion of the supernate, to form a dilated cell-slurry, the dilated cell-slurry being transferred from the fluidizing system to the syringe, while maintaining at least a portion of the supernate, the cell-slurry and supernate being transferred from the fluidizing system to the syringe, a pressurizing mechanism adapted to create a pressure to cause the dilated cell-slurry contained within the syringe to flow for delivery to the patient and a control unit in communication with and adapted to control the fluidizing system, the pressurizing mechanism and movement of the dilated cell-slurry.
    US9814827:A system for delivering to a patient a slurry which includes a fluid and a material that is non-dissolvable or immiscible in the fluid. The system includes a container adapted to contain the slurry and a supernate of the slurry, a syringe adapted to contain the slurry after dilation with the supermate, a fluid path between the syringe and the contents of the container, the fluid path including a needle at least partially disposed within the contents of the container, a plunger disposed in the syringe and adapted to create pressure in the syringe to cause a dilated slurry to flow into the syringe through the fluid path, and a fluidizing systen associated with the container and comprising a holder adapted to move the needle within the container to affect dilation of the slurry with a portion of the supernate.
    US7713232:A system for injecting an injectate into patient includes a first pressurizable container for holding the injectate; a patient interface in fluid connection with the first pressurizable container, the patient interface being adapted to pass the injectate into tissue of the patient; a powered injector in operative connection with the first pressurizable container to pressurize the injectate; a controller system in operative connection with powered injector; and a stereotactic localization frame adapted to be placed in operative connection with the patient interface to assist in controlling localization of the patient interface. A system for processing cells (and/or other injectate components) includes a container and a plunger adapted to be slidably positioned within the container. The system includes at least one inlet port through which a fluid can enter the system and at least one effluent port through which an effluent can exit the system. The plunger section forms a sealing engagement with the inner wall of the container such that rearward motion of the plunger is adapted to draw fluid into the system via the inlet and forward motion of the plunger is adapted to force effluent out of the system via the effluent port.
    60/771,206:Provisional Application Expired
    60/742,224:Provisional Application Expired
    60/734,035:Provisional Application Expired
    US9629780:A container adapted to store and transport an injectate is disclosed. The container includes a divider which extends from an open top end toward a closed bottom end, the divider spaced apart from the closed bottom end to define an opening and separating the container into a first fluid path on a first side of the divider through which fluid can enter the container through the inlet port and a second fluid path on a second side of the divider through which fluid can enter the opening and exit the container through the outlet port. The second fluid path includes at least one filter between the opening and the open top end through which fluid can pass from the first fluid path to the second fluid path but through which at least one component of the injectate cannot pass.
    US8414765:A system for processing cells is disclosed. The system may include a container having an inner wall, a plunger adapted to be slidably positioned within the container, at least one inlet port through which a fluid can enter the container, at least one outlet port through which a fluid can exit the container, at least one effluent port through which an effluent can exit the container, a first check valve in fluid connection with the inlet port and a second check valve in fluid connection with the effluent port. The plunger may include a filter that allows fluid to pass therethrough but prevents cells from passing therethrough. Rearward motion of the plunger may be adapted to draw fluid into the system via the inlet port and forward motion of the plunger may be adapted to force effluent out of the system via the effluent port.
    US8182444:A system for delivering a fluid comprising cells to tissue of a patient includes a container holding an injection fluid and a powered drive. A sensor system provides a measurement indicative of at least shear forces on the cells to a control system. Based at least in part on this measurement, the control system is adapted to transmit a control signal to the powered drive for pressurizing the contents of the container to deposit cells within the tissue of a patient via a fluid path and a patient interface. As an example, the cells can be pregenitor or stem cells.
    EP20060836954.5:
    CA2630686:
    JP2009524442:
    US14361357:A system includes at least one pressurizing mechanism, a fluid path adapted to be placed in operative connection with the pressurizing mechanism to deliver an injectate to a patient, wherein the injectate includes cells, a control system operably associated with the at least one pressurizing mechanism; and at least one parameter generation system in operative connection with the control system. The parameter generation system includes an input system to receive data of a type of cells to be injected and is adapted to generate at least one parameter for the injection procedure at least in part on the basis of the data of the type of cells. The at least one parameter for the injection procedure may, for example, be a variable associated with the injectate, a variable associated with an injection protocol or a variable associated with at least one component of the fluid path.
    61/566,139:
    EP20120853035:

terracaptus